PHARMACYTE BIOTECH, INC.
Asset & Liabilities Breakdown
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
Asset Breakdown FY2011
Total Assets: $1.2M
Liabilities Breakdown FY2011
Total Liabilities: $3.4M
Asset Breakdown
Total Assets: $1.2M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $57.2K | 4.6% |
| Accounts Receivable | $2.3K | 0.2% |
| Inventory | $18.7K | 1.5% |
| Property, Plant & Equipment | $54.4K | 4.4% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $1.1M | 89.3% |
Liabilities Breakdown
Total Liabilities: $3.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $705.8K | 20.8% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $2.7M | 79.2% |